Onduo

Why Novartis and Verily should abandon their smart lens idea

https://pharmaphorum.com/views-and-analysis/novartis-verily-abandon-smart-lens-idea/

Digital Health Round-up – Verily’s diabetes ambitions; IBM Watson in Finland

https://pharmaphorum.com/views-and-analysis/digital-health-round-verilys-diabetes-ambitions-ibm-watson-finland/

Google alliance Onduo central to Sanofi’s diabetes revival

https://pharmaphorum.com/views-and-analysis/google-alliance-onduo-central-sanofis-diabetes-revival/

Close in 10 seconds

Pharmaphorum.com

Search